International Search Report, International Application No. PCT/US00/21022, Dated Jan. 22, 2001. |
McCarty et al., “Historical Perspective on C-Reactive Protein,” Laboratory of Bacteriology and Immunology, vol. 389, 1982, pp. 1-10. |
Simmons A., “Technical Hematology (Third Edition),” National Health Laboratories, Plainview, NY, pp. 334-5. |
Rowe et al., “Circulating Human C-Reactive Protein Binds Very Low Density Lipoproteins,” Clin. Exp. Immunol., 1984, No. 58, pp. 237-244. |
Rowe et al., “Rabbit and Rat C-Reactive Proteins Bind Apolipoprotein B-Containing Lipoproteins,” J. Exp. Med., 1984, vol. 159, pp. 604-16. |
Gewurz et al., “C-Reactive Protein and the Acute Phase Response,” Advances in Internal Medicine, 1982, 27: pp. 345-372. |
Sammalkorpi et al., “Lipoproteins and Acute Phase Response During Acute Infection. Interrelationships Between C-Reactive Protein and Serum Amyloid-A Protein and Lipoproteins,” Annals of Medicine, 1990, 22: pp. 397-401. |
Stewart et al., “Sensitive and Rapid Measurement of C-Reactive Protein (CRP) by Lipid Agglutination,” Dept. of Laboratory Medicine, Nov. 1986, pp. 585-8. |
Hulman et al., “Comparison of Fat Agglutination Slide Test and Latex for C-Reactive Protein,” Clinica Chimica Acta, 165, (1987), pp. 89-93. |
Lagrand et al., “C-Reactive Protein as a Cardiovascular Risk Factor More Than an Epiphenomenon?,” Circulation Jul. 1999, pp. 96-102. |
Hulman, G., “The Pathogenesis of Fat Embolism,” Journal of Pathology, 1995, vol. 176: pp. 3-9. |
Lindh et al., “Agglutinate Formation in Serum Samples Mixed With Intravenous fat Emulsions,” Critical Care Medicine, vol. 13, No. 3, 1985, pp. 151-3. |
Husebekk et al., “High-Density Lipoprotein has Different Binding Capacity for Different Apoproteins the Amyloidogenic Apoproteins are Easier to Displace from High-Density Lipoprotein,” Scan. J. Immunol., 28, (1988), pp. 653-658 (abstract only). |
Husebekk et al., “High-Density Lipoprotein has Different Binding Capacity for Different Apoproteins the Amyloidogenic Apoproteins are Easier to Displace from High-Density Lipoprotein,” Scan. J. Immunol., 28, (1988), pp. 653-658 (abstract only). |
Eitoku et al., “Studies on the Serum Amyloid A (SAA): Part 2 Latex Agglutination Nephelometric Immunoassay System for the Quantitation of SAA in Human Serum and its Clinical Values,” Physico Chem. Biol., vol. 37, (1993), No. 1, pp. 19-23 (abstract only). |
McDonald et al., “A monoclonal Antibody Sandwich Immunoassay for Serum Amyloid A (SAA) Protein,” J. Immunol. Methods, 1991, 144, No. 2, pp. 149-155 (abstract only). |
Wilkins et al., “Rapid Automated Enzyme Immunoassay of Serum Amyloid A,” Clin. Chem, 1994, vol. 40, No. 7, Part 1, pp. 1284-1290 (abstract only). |
Harris et al., “Reactivity of Serum Amyloid P Component with C-Reactive Protein and IgM,” Clin. Res., 37, (1989), No. 2, 614A (abstract only). |
Christner et al., “Specificity of the Binding Interaction Between Human Serum Amyloid P-component and Immobilized Human C-Reactive Protein,” J. Biol. Chem., 1994, 269, No. 13, pp. 9760-6 (abstract only). |
Swanson et al., “Human Serum Amyloid P-component (SAP) Selectively binds to Immobilized or Bound Forms of C-Reactive Protein (CRP),” Biochem. Biophys. Acta, 1992, 1160, No. 3, pp. 309-316 (abstract only). |
Robin et al., “Prognostic Value of Waveform Analysis in the Intensive Care Setting,” Intensive Care Med., 1999:25 (Supplement 1): S63. |
Toh et al., “A Previously Unrecognised Mechanism that is Calcium-dependent and Thrombin-independent Characterises the Pre-DIC State,” The American Society of Hematology, 1999 Submission Form (Draft Preview of Abstract #450426). |
Toh et al., “Prospective Detection of Pre-Disseminated Intravascular Coagulation (DIC) in a Sepsis Cohort by Waveform Analysis,” XVIIth Congress International Society for Thrombosis & Haemostasis, Aug. 1999 (abstract submission form). |
Toh et al., “APTT Waveform Analysis: Predicting Mortality in the Critical Care Setting Using the Light Transmittance Level at 18 Seconds,” XVIIth Congress International Society for Thrombosis & Haemostasis, Aug. 1999 (abstract submission form). |
Toh et al., “Waveform Analysis of the Prothrombin Time (PT) Assay also Shows Characteristic Changes in Disseminated Intravascular Coagulation,” XVIIth Congress International Society for Thrombosis & Haemostasis, Aug. 1999 (abstract submission form). |
Downey et al., “The Robustness and Reproducibility of APIT Waveform Analysis in Relation to Reagent and Batch Variation,” (abstract only). |
Dennis et al., “Utility of Prothrombin Time Waveform Analysis in the Routine Clinical Setting,” Sep. 1999 (abstract submission form). |
Toh et al., “Impending Clinical Decompensation is Characterised by the Detection of a Novel Calcium-dependent and Thrombin-independent Pathway,” 5th World Congress on Trauma, Shock, Inflammation and Sepis—Pathophysiology, Immune Consequences and Therapy, Feb. 2000 (abstract submission form). |
Toh et al., “Characterisation of the Novel Calcium-Activation, Thrombin Suppression Assay (CaTs) in the DIC of Sepsis,” abstract only). |
Toh et al., “The Mechanism Underlying the Atypical Clot Waveform Profile of DIC is Thrombin-independent but Calcium-dependent,” European Haematology Association, Jun. 2000 (abstract only). |
Schwalbe et al., “Association of Rat C-Reactive Protein and Other Pentraxins with Rat Lipoproteins Containing Apolipoproteins E and A1,” Biochemistry, 1995, 34 (33), 10432-9. |
Toh et al., “Disseminated Intravascular Coagulation (DIC): Old Problem, New Hope,” Clinical Hemostasis Review, Jan. 1998. |
Downey et al., “Novel and Diagnostically Applicable Information from Optical Waveform Analysis of Blood Coagulation In Disseminated Intravascular Coagulation,” British Journal of Haematology, 1997.97.000-000. |
Downey et al., “Transmittance Waveforms-Adjunctive Information from Automated Coagulometers,”International Journal of Hematology, Abstracts of the 26th Congress of the International Society of Haematology 25-29, Aug. 1996 (abstract only). |
Engler, R., “Acute-phse Proteins in Inflammtion,” CR Seances Soc. Biol. Fil., 1995, vol. 189 (4), pp. 563-78 (abstract only). |
Rybarska et al., “The Detection of Specific Acute Phase Serum Protein Complexes and Immune Complexes by Congo Red Binding,” Journal Physiology and Pharmacology, 1995, vol. 46(2), pp. 221-31 (abstract only). |
Maury, C.P.J., “Clinical Usefulness of Serum amyloid A and C-reactive Protein Measurements in Inflammatory Disorders a Comparative Study,” Marker Proteins in Inflammation Proceedings, vol. 3, Symposium, Lyon, France, Jun. 1985 (abstract only). |
Richter et al., “The Fat Emulsion Agglutination Test: A Reliable and Cost Effective Alternative to the Latex Agglutination Test for Rapid Bedside CRP Measurement,” Clinica Chimica Acta, 261, 1997, pp. 141-148. |
Rowe et al., “Agglutination of Intravenous Lipid Emulsion (‘Intralipid’) and Plasma Lipoproteins by C-reactive Protein,” Clin. Exp. Immunol., 1986, No. 66, pp. 241-7. |
Hulman et al., “Agglutination of Intralipid by Sera of Actuely III Patients,” The Lancet, Dec. 1982, p. 1426. |
Cabana et al., “Interaction of Very Low Density Lipoproteins (VLDL) with Rabbit C-reactive Protein,” J Immunol, 1982, vol. 128 (5), pp. 2342-8 (abstract only). |
Cabana et al., “Inflammation-induced Changes in Rabbit CRP and Plsma Lipoproteins,” J Immunol, 1983, vol. 130(4), pp. 1736-42 (abstract only). |
Cabana et al., “Effects of the Acute Phase Response on the Concentration and Density Distribution of Plasma Lipids and Apolipoproteins,” J Lipid Res.1989, vol. 30(1), pp. 39-49 (abstract only). |
de Beer et al., “Low Density Lipoprotein and Very Low Density Lipoprotein are Selectively Bound by Aggregated C-reactive Protein,” J Exp Med., 1982, vol. 156(1), pp. 230-42 (abstract only). |
Pepys et al., “C-reactive Protein: Binding to Lipids and Lipoproteins,” Int Rev Exp Pathol., 1985, vol. 27, pp. 83-111 (abstract only). |
Rowe et al., “In vivo Turnover Studies of C-reactive Protein and Lipoproteins in the Rabbit,” Clin Exp Immunol, vol. 58(1), pp. 245-52 (abstract only). |
Cabana et al., “Effects of the Acute Phase Response on the Concentration and Density Distribution of Plasma Lipids and Apolipoproteins,” Journal of Lipid Research, vol. 30, 1989, pp. 39-49. |
Canivet et al., “Postoperative Changes in Lipid Profile: Their Relations with Inflammatory Markers and Endocrine Mediators,” Acta Anaesthesiologica Belgica, vol. 40 (4), 1989. |
Atherotech—VAP/CAD Lipoprotein Risk Assessment Test, Sample of VAP Profile. |
Malle et al., “Serum Amyloid A (SAA): An Acute Phase Protein and Apolipoprotein,” Atherosclerosis 1993, 102, pp. 131-146. |
3 × 15 Test Kit for Detection of Plasma Protein C Activity Using a Clotting End-Point, Product # ACC-45, American Diagnostica Inc., 1-2 (Feb. 1989). |
Astion, et al., Overtraining in neural networks that interpret clinical data, Clin. Chem., 39(9):1998-2004 (1993). |
Astion, et al., The application of backpropagation neural networks to problems in pathology and laboratory medicine, Arch. Pathol. Lab. Med., 116:995-1001 (Oct. 1992). |
Baum and Haussler, What size net gives valid generalization?, Neural Computation, pp. 81-89 (Jan. 1989). |
Baumann, et al., Computerized analysis of the in vitro activation of the plasmatic clotting system, Haemostasis, 19:309-321 (1989). |
Bluestein and Archer, The sensitivity, specificity and predictive value of diagnostic information: a guide for clinicians, Nurse Practitioner, 16(7):39-45 (Jul. 1991). |
Boone et al., Neural networks in radiologic diagnosis, Investigative Radiology, 25(9):1013-1023 (Sep. 1990). |
Brandt, et al., Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program, Arch.Pathol.Lab Med., 115:109-114 (Feb. 1991). |
Braun et al., Examination of prothrombin time (PT) and activated partial thromboplastin time (APTT) optical clot profiles using an automated thromobosis-hemostasis, Coagulation Methods Instrumentation and Quality Control, p. 1236, Abstract #1286 (1995). |
Braun, et al., Properties of optical data from activated partial thromboplastin time and prothrombin time assays, Thromb. Haemost., 78:1079-1987 (1997). |
Carrol, et al., Ortho Educational Monograph, The Clot Signature and New Aspects in Coagulation Testing, Ortho Diagnostic Systems, Inc., pp. 1-20 (1989). |
Dassen, et al., Self-learning neural networks in electrocardiography, J. Electrocardiol., 23 Suppl:200-202 (1990). |
Furlong, et al., Neural network analysis of serial cardiac enzyme data. A clinical application of artificial machine intelligence, Am.J.Clin.Pathol., 96(1):134-141 (Jul. 1991). |
Givens and Braun, Classification of factor deficiencies from coagulation assays using neural networks, Int.J.Med.Inf., 46:129-143 (1997). |
Givens et al., Interpretation of clot formation parameters from APTT and PT assays using neural networks, Clin.Chem., 42(6):S192, Abstract #399 (1996). |
Givens, et al., Predicting the presence of plasma heparin using neural networks to analyze coagulation screening assay optical profiles, Comput.Biol.Med., 26(6):463-476 (1996). |
Givens, T.B., Clot signatures, Clin.Hemostasis Rev., pp. 11-12 (Aug. 1997). |
Heuck and Baumann, Kinetic analysis of the clotting system in the presence of heparin and depolymerized heparin Haemostasis, 21:10-18 (1991). |
Hoffman and Callahan, The Coag-A-Mate RA4 Fibrinogen Assay, Interface (Organon Teknika), pp. 3-7 (1990). |
Koagulab 16-S Plus Graphics, Koagulab 32-S Coagulation System, Graphics Binder, 2,3,5,6,8-12, 14-17, 19-21, 23. |
Khanin and Semenov, A mathematical model of the kinetics of blood coagulation, J. Theor.Biol., 136:127-134 (Jan. 1989). |
Package insert for Ortho Brain Thromboplastic Reagent, Ortho Diagnostic System, Inc., pp. 1-7 (Oct. 1985). |
Pattichis, et al., Efficient training of neural network models in classification of electromyographic data, Med.Biol.Eng Comput., 33(3):499-503 (May 1995). |
Pohl, et al., The quick machine-a mathematical model for the extrinsic activation of coagulation, Haemostasis, 24:325-337 (1994). |
Sabbatini, R.M.E., Neural networks for classification and pattern recognition of biological samples, Conf.of the Engineering in Medicine and Biology Society (IEEE, New York, U.S.) 15:265-266 (Oct. 1983). |
Schweiger, et al., Evaluation of laboratory data by conventional statistics and by three types of neural networks, Clin.Chem., 39(9):1966-1971 (1993). |
Sweeney et al., Abnormal clot signatures in hereditary bleeding disorders, Blood, 74 Suppl 1(7):395, Abstract #1509 (Nov. 1989). |
Sweeney et al., Abnormal clot signatures in hereditary bleeding disorders, The American Society of Hematology Abstract Reproduction Form (1989). |
Sweeney et al., Kinetic clot parameters in gynecological tumors, Blood, 76 Suppl 1(10):439a, Abstract #1745-(Nov. 1990). |
Swets, J. A., Measuring the accuracy of diagnostic systems, Science, 240:1285-1293 (Jun. 1988). |
Talstad, I., Which coagulation factors interfere with the one-stage prothrombin time?, Haemostasis, 23:19-25 (1993). |
Triplett, et al., Graphic monitoring of coagulation assays, American Clinical Laboratory, pp. 1-5 (Apr. 1989). |
Zweig and Campbell, Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine, Clin.Chem., 39(4):561-577 (1993). |
Ortho Factor VIII: C Deficient Plasma, Ortho Diagnostic Systems, Inc., pp. 1-2 (Sep. 1998). |
C. Downey, et al. Br. J. Haematol., 136: 18854 (1997). |
Baumann et al., “Simulation of the extrinsic pathway of the plasmatic clotting system,” Haemostasis, 21:329-337 (1991). |
Zuckerman et al. “Comparison of thrombelastography with common coagulation tests,” Thromb Haemostas, 46: 752-756 (1981). |